CVS Health Analysts Recommendations and Consensus

CVS -- USA Stock  

Quarterly Earning Report: November 6, 2019  

The current analyst and expert consensus on CVS Health is Buy with 6 hold recommendations. The current projected target price consensus is 73.85 with 20 analysts opinions. One of the most common ways CVS Health analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to CVS Health vendors, executives, and/or customers. CVS Health recommendation module provides expert sentiment on the projected CVS Health target price to derive its highest and lowest estimates based on target price standard deviation of 9.365. Check also Macroaxis Advice on CVS Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

CVS Health Target Price Consensus

Number of Opinions21
Lowered Outlook0
Raized Outlook0
Buy
Macroaxis Recommendation   Exposure   Valuation

CVS Health Target Price Projection

Current Price

CVS Health Market Quote

Low Price63.48Odds
High Price64.97Odds

64.83

Target Price

Analyst Consensus On Target Price

Low Estimate58.0Odds
High Estimate91.0Odds
Number of Analysts20
Standard Deviation9.365

73.85

CVS Health Analysit Ratings

Average Consensus

Search macroaxis.com